MD, PhD, Founder, Chief Scientific Officer
Dr. Siemionow spent decades investigating the effects of chimeric cells – created by fusion of donor and recipient bone marrow derived stem cells – on the immune system’s natural attack response to foreign tissues and donor organs.
MD, PhD, Co-Founder and CEO
Dr. Kris Siemionow is a board certified orthopaedic surgeon and an entrepreneur, who founded and co-founded multiple medical companies, that utilize advanced technology to improve clinical outcomes.
Professor, Co-Founder, Board member
Dr. Paul Lewicki is a cognitive scientist, an entrepreneur, investor, and a Big Data pioneer who founded StatSoft (offices in 30 countries, over 1 million accounts) acquired by Dell.
You are now leaving Dystrogen Therapeutics